A two-step scoring model incorporating visceral-to-subcutaneous fat ratio and systemic immunoinflammatory index for predicting cytokine release syndrome severity in patients with gastric cancer receiving Claudin18.2-targeted CAR-T cell therapy.

Cancer Immunol Immunother · 2026 · PMC12972397 · PMID 41801430

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline non-significantP = 0.051so close (0.05 < p ≤ 0.1)

While SFA showed a borderline non-significant trend toward being higher in patients with CRS grade 1 than those with grade 2 (80.95 [52.09] vs. 52.71 [42.36] cm 2 , respectively; P = 0.051).

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.